Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Adrenal Insufficiency × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 47 Prostatic Neoplasms 22 Neoplasms 19 Multiple Myeloma 16 Papillomavirus Infections 12 Carcinoma, Non-Small-Cell Lung 12 Carcinoma, Hepatocellular 12 Stomach Neoplasms 11 Colorectal Neoplasms 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Lung Neoplasms 9 Pain, Postoperative 8 Neoplasm Metastasis 8 Waldenstrom Macroglobulinemia 6 Recurrence 6 Polycystic Ovary Syndrome 6 Ovarian Neoplasms 6 Melanoma 6 Hematologic Neoplasms 6 Lymphoma, Non-Hodgkin 5 Lymphoma, Follicular 5 Leukemia, Myeloid, Acute 5 Leiomyoma 5 Kidney Neoplasms 5 Agnosia 5 Venous Thromboembolism 4 Urinary Bladder Neoplasms 4 Thyroid Neoplasms 4 Smoking Cessation 4 Pain 4

Interventions

ravulizumab 1 Prednisone 1 Prednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07221838 2026-03-03

OCTAGON

Alexion Pharmaceuticals, Inc.

Phase 4 Not yet recruiting

Adrenal Insufficiency, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡